NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing essential chemical compounds for the pharmaceutical industry, and Lapatinib Ditosylate Powder is a prime example of our commitment to quality and innovation. This powerful substance serves as a critical pharmaceutical intermediate in the development of advanced cancer therapies, particularly for conditions like HER2-positive breast cancer.

Chemically, Lapatinib Ditosylate is a quinazoline derivative with the molecular formula C29H26ClFN4O4S. Its CAS number is 388082-78-8. As a synthetic compound, it is designed to specifically target and inhibit tyrosine kinases. Its primary mechanism of action involves the reversible blockade of phosphorylation in the epidermal growth factor receptor (EGFR) and the HER2/neu receptor. These receptors are often overexpressed in various cancer cells, driving uncontrolled growth and proliferation. By inhibiting these pathways, Lapatinib Ditosylate effectively curtails tumor progression.

The therapeutic applications of Lapatinib Ditosylate powder are extensive, primarily within oncology. It is a key component in treatments for advanced or metastatic breast cancer, especially in cases where the tumors overexpress HER2 (ErbB2). Its efficacy in combination therapy has made it an invaluable tool for clinicians managing these complex cases. The oral administration route enhances patient convenience, making it a preferred choice for long-term management of the disease. This makes it a significant anticancer drug precursor.

For manufacturers and researchers looking to buy Lapatinib Ditosylate online, understanding its properties is crucial. The powder form ensures ease of handling and incorporation into various formulations. NINGBO INNO PHARMCHEM CO.,LTD. guarantees high purity, typically exceeding 99%, ensuring that the compound meets the rigorous standards required for pharmaceutical manufacturing. Our role as a leading manufacturer of such intermediates underscores our dedication to supporting the global healthcare sector.

The broad impact of Lapatinib Ditosylate as a tyrosine kinase inhibitor is a testament to modern pharmaceutical research. Its ability to target specific molecular pathways offers a more precise and often more tolerable treatment regimen for patients. As a trusted supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures that this vital compound is accessible, with competitive pricing for Lapatinib Ditosylate powder, enabling further research and the production of life-saving treatments. Our commitment is to facilitate the advancements in cancer care through the provision of superior pharmaceutical intermediates.